Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CVM UNTITLED LETTERS.


These letters are the regulatory activity letters issued by the Division of Epidemiology and Surveillance, Office of Surveillance and Compliance to makers of veterinary drugs. Copies are available from our RECORD-RETRIEVE service for $7 plus retrieval.

10613W

Alpharma Animal Health, Ft. Lee, NJ, April 11 (CVM Division of Epidemiology and Surveillance). FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 cited Alpharma for lack of a distributor statement on file for an entity the name of which was purged. The letter noted that hexamitiasis, an infection of the gastro-intestinal tract by parasitic Hexamida meleagridis, was not among the cleared indications for the unnamed, tetracycline-based drug that was the subject of a new animal drug application (NADA). The letter was prompted by an annual drug experience report filed by Alpharma on Aug. 17, 2000.

10614W

Merck & Co., Rahway, NJ, April 24 (CVM Division of Epidemiology and Surveillance). The letter stated that a labeling item for Heartgard Plus (ivermectin/pyrantel) compared the drug with milbemycin oxime oxime /ox·ime/ (ok´sem) any of a series of compounds containing the CH(dbondNOH) group, formed by the action of hydroxylamine upon an aldehyde or a ketone.

ox·ime
n.
 (MBO MBO

See: Management buyout
) products and selamectin in treatment of canine parasites with zoonotic potential that may "call into question the efficacy" of MBOs in the treatment of Ancylostoma caninum. FDA insisted the comparison constituted "false or misleading representations" about the MBO products. The agency cited both the labeling and a print ad for lack of fair balance because they did not present risk associated with Heartgard Plus, including ataxia ataxia (ətăk`sēə), lack of coordination of the voluntary muscles resulting in irregular movements of the body. Ataxia can be brought on by an injury, infection, or degenerative disease of the central nervous system, e.g.  and convulsions Convulsions
Also termed seizures; a sudden violent contraction of a group of muscles.

Mentioned in: Heat Disorders
, "in the same scope, depth and detail" as benefits. F-B F-B Forward - Backward (radar image analysis)  
COPYRIGHT 2001 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Warning Letter Bulletin
Date:Jul 16, 2001
Words:235
Previous Article:FOODS/DIETARY SUPPLEMENTS.
Next Article:ANIMAL DRUGS/FEED.



Related Articles
DDMAC triples warnings.
Advertising enforcement jumps at CBER, CVM.
Congress urged to give FDA power to levy fines for ads - Agency disputes 50% drop in enforcement.
CVM UNTITLED LETTERS.
Warning letter review by Chief Counsel may slow enforcement.
Chief Counsel's review of warnings awaiting SOPs.
'Pharmaceutical Inspectorate' and team inspections created for human, animal drugs: all Part 11 guidance, CPG revoked.
FDA concerns rising over animal drug ads, but fewer warning letters are issued.
FDA drug advertising letters total 32 for all centers in '03: DTC ad guidance expected by year's end.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles